NR4A1 and breast cancer: Another important finding related to BC is that some patients with hormone receptor-positive (HR+) tend to have more aggressive BC possibly due to the dysbiosis that triggers the early inflammation in the mammary gland during the progression of HR+ breast tumor by disrupting the mammary tissue homeostasis (Rosean et al., 2019).